Table 2.
Maternal and neonatal clinical characteristics for twin-to-twin transfusion syndrome cases selected for fetoscopic laser therapy before (2019) and during the COVID-19 pandemic (2020)
| Characteristic | 2019 (n=50) | 2020 (n=41) | P valuea |
|---|---|---|---|
| Maternal age (y) | 30.0 (6.0) | 29.5 (5.5) | .67 |
| BMI (kg/m2) | 26.4 (5.5) | 27.8 (6.6) | .30 |
| Primiparity | 38.0 | 46.3 | .42 |
| TTTS staging | |||
| I | 30.0 | 22.0 | .39 |
| II | 34.0 | 29.3 | .63 |
| III | 20.0 | 34.0 | .13 |
| IV | 16.0 | 14.6 | .86 |
| Late TTTS stage (III–IV) | 36.0 | 48.8 | .22 |
| Cervical length (mm) | 29.3 (11.1) | 28.5 (10.0) | .74 |
| Short cervix | 8.0 | 14.6 | .31 |
| GA at fetoscopy (wk) | 22.8 (3.3) | 22.6 (3.3) | .78 |
| Drained amniotic fluid (mL) | 1727 (1625) | 1986 (1446) | .43 |
| Surgery time (min) | 25.0 (12.8) | 24.6 (21.9) | .92 |
Data are presented as mean (standard deviation) or percentage, unless otherwise indicated.
BMI, body mass index; GA, gestational age; TTTS, twin-to-twin transfusion syndrome.
a
The Student t test for independent samples or the Pearson chi-squared test was used.
López-Briones. Twin-to-twin transfusion syndrome and COVID-19. Am J Obstet Gynecol Glob Rep 2022.